HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Amelie Lupp Selected Research

pasireotide

6/2021Gender-Specific Efficacy Revealed by Head-to-Head Comparison of Pasireotide and Octreotide in a Representative In Vivo Model of Nonfunctioning Pituitary Tumors.
8/2011Differential antiinflammatory and antinociceptive effects of the somatostatin analogs octreotide and pasireotide in a mouse model of immune-mediated arthritis.
2/2010Pasireotide and octreotide stimulate distinct patterns of sst2A somatostatin receptor phosphorylation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Amelie Lupp Research Topics

Disease

28Neoplasms (Cancer)
11/2023 - 04/2010
9Sepsis (Septicemia)
01/2021 - 10/2009
8Liver Diseases (Liver Disease)
01/2018 - 01/2003
7Neuroendocrine Tumors (Neuroendocrine Tumor)
11/2023 - 01/2011
7Inflammation (Inflammations)
01/2021 - 01/2008
4Carcinoma (Carcinomatosis)
02/2021 - 04/2010
4Small Cell Lung Carcinoma (Small Cell Lung Cancer)
02/2021 - 03/2015
4Carcinoid Tumor (Carcinoid)
02/2021 - 02/2010
3Adenoma (Adenomas)
04/2020 - 01/2011
3Endotoxemia
10/2016 - 02/2008
3Alzheimer Disease (Alzheimer's Disease)
04/2014 - 06/2003
3Body Weight (Weight, Body)
01/2008 - 06/2003
2Renal Insufficiency (Renal Failure)
04/2020 - 06/2003
2Adenocarcinoma
10/2019 - 10/2018
2Infections
08/2017 - 02/2013
2Lymphoma (Lymphomas)
01/2017 - 11/2016
2Cholestasis
02/2013 - 01/2012
2Pain (Aches)
09/2011 - 08/2011
2Myositis (Idiopathic Inflammatory Myopathies)
01/2008 - 07/2005
2Myalgia
01/2008 - 07/2005
2Hypertrophy
01/2008 - 07/2005
2Gastrointestinal Diseases (Functional Gastrointestinal Disorders)
01/2008 - 07/2005
2Eosinophilia
01/2008 - 07/2005
1Shock
01/2023
1Ischemia
01/2023
1Wounds and Injuries (Trauma)
01/2023
1Reperfusion Injury
01/2023
1Fibrosis (Cirrhosis)
12/2022
1Insulinoma
11/2022
1Follicular Adenocarcinoma
07/2022
1Anaplastic Thyroid Carcinoma
07/2022
1Thyroid Neoplasms (Thyroid Cancer)
07/2022
1Pituitary Neoplasms (Pituitary Adenoma)
06/2021
1Neuroendocrine Carcinoma
09/2020
1Prostatic Neoplasms (Prostate Cancer)
09/2020
1Secondary Hyperparathyroidism
04/2020
1Primary Hyperparathyroidism
04/2020
1Osteonecrosis (Kienbock's Disease)
01/2019
1Neoplasm Metastasis (Metastasis)
01/2019
1Hip Osteoarthritis (Coxarthrosis)
01/2019
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
10/2018

Drug/Important Bio-Agent (IBA)

17Somatostatin (Somatotropin Release-Inhibiting Factor)IBA
11/2023 - 01/2011
15Somatostatin Receptors (Somatostatin Receptor)IBA
11/2023 - 01/2011
10Monoclonal AntibodiesIBA
07/2022 - 01/2011
9Chemokine ReceptorsIBA
07/2022 - 02/2015
8Proteins (Proteins, Gene)FDA Link
12/2022 - 03/2015
6somatostatin receptor type 1IBA
11/2022 - 08/2011
4EnzymesIBA
12/2022 - 01/2003
4CXCR4 Receptors (CXCR4 Receptor)IBA
07/2022 - 04/2010
4AcidsIBA
10/2018 - 01/2017
4LipopolysaccharidesIBA
01/2018 - 02/2013
4CytokinesIBA
08/2017 - 02/2013
3Octreotide (Sandostatin)FDA LinkGeneric
06/2021 - 02/2010
3pasireotideIBA
06/2021 - 02/2010
3ParaffinIBA
02/2021 - 03/2015
3ChemokinesIBA
10/2019 - 10/2017
3Messenger RNA (mRNA)IBA
10/2018 - 03/2015
3Sphingomyelin Phosphodiesterase (Sphingomyelinase)IBA
10/2018 - 01/2017
3somatostatin receptor 2IBA
11/2016 - 01/2012
3AntibodiesIBA
11/2016 - 01/2012
2AntioxidantsIBA
01/2023 - 09/2011
2LigandsIBA
11/2022 - 02/2021
2Formaldehyde (Formol)FDA Link
02/2021 - 03/2015
2Interleukin-10 (Interleukin 10)IBA
01/2021 - 10/2013
2CeramidesIBA
10/2018 - 04/2017
2Desipramine (Pertofrane)FDA LinkGeneric
10/2018 - 04/2017
2Endothelin A ReceptorIBA
07/2018 - 10/2017
2SuspensionsIBA
12/2016 - 02/2013
2EndotoxinsIBA
01/2015 - 02/2013
2BilirubinIBA
02/2013 - 01/2012
2Tacrine (Cognex)FDA Link
06/2012 - 01/2010
2ciprofibrateIBA
01/2008 - 07/2005
2Therapeutic UsesIBA
01/2008 - 07/2005
2GlycogenIBA
01/2008 - 07/2005
2Glycine (Aminoacetic Acid)FDA LinkGeneric
01/2008 - 06/2003
1Biomarkers (Surrogate Marker)IBA
11/2023
1LyasesIBA
01/2023
1CystathionineIBA
01/2023
1sodium thiosulfateFDA Link
01/2023
1Neural Cell Adhesion Molecules (Neural Cell Adhesion Molecule)IBA
11/2022
1GTP-Binding Proteins (G-Protein)IBA
11/2022
1Dopamine Receptors (Dopamine Receptor)IBA
11/2022
1Chromogranin AIBA
11/2022
1Phosphopyruvate Hydratase (Enolase)IBA
11/2022
1Serotonin (5 Hydroxytryptamine)IBA
11/2022
1SynaptophysinIBA
11/2022
1Anaphylatoxin C5a ReceptorIBA
01/2021
1Complement C5a (Complement 5a)IBA
01/2021
1Complement System Proteins (Complement)IBA
01/2021
1CalciumIBA
04/2020
1Cinacalcet (Sensipar)FDA Link
04/2020
1RANK LigandIBA
01/2019
1OsteoprotegerinIBA
01/2019
1Parathyroid Hormone (Parathormone)IBA
01/2019
1Mixed Function Oxygenases (Monooxygenases)IBA
10/2018

Therapy/Procedure

10Therapeutics
07/2022 - 06/2003
2Liver Transplantation
01/2023 - 01/2018
2Punctures
04/2020 - 08/2017
2Drug Therapy (Chemotherapy)
11/2017 - 01/2012
2Oral Administration
01/2008 - 07/2005